D. DeBrota

发表

Changes in Brain Function during Administration of Venlafaxine or Placebo to Normal Subjects

A. Hunter, A. Leuchter, I. Cook, 2008, Clinical EEG and neuroscience.

Input modeling with the Johnson System of distributions

S. D. Roberts, J. J. Swain, S. Venkatraman, 1988, 1988 Winter Simulation Conference Proceedings.

Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.

B. Neuschwander‐Tetri, V. Miller, A. Sanyal, 2017, Gastroenterology.

Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET).

J. Mundt, J. Greist, D. DeBrota, 2007, Psychiatry (Edgmont (Pa. : Township)).

Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase‐1

J. Suico, D. DeBrota, M. Luo, 2018, Journal of clinical pharmacology.

The Impact of Restrictive Entry Criterion During the Placebo Lead‐in Period

M. Demitrack, W. Potter, D. DeBrota, 2000, Biometrics.

Comparison of Interactive Voice Response SF-36 to Self-Administered SF-36 and Personal Interview via Telephone SF-36.

David J. DeBrota, Edward W. Bradt, Carol M. Andrejasich, 1996 .

Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.

D. DeBrota, C. Payne, M. Deeg, 2014, British journal of clinical pharmacology.

Site Versus Centralized Raters in a Clinical Depression Trial: Impact on Patient Selection and Placebo Response

A. Leon, J. Alpert, K. Kobak, 2010, Journal of clinical psychopharmacology.

Study of the analgesic effect of lanepitant in patients with osteoarthritis pain

S. Iyengar, B. Gitter, D. DeBrota, 2000, Clinical pharmacology and therapeutics.

An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.

D. Santor, D. DeBrota, S. Gelwicks, 2004, Journal of psychiatric research.

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data

Geert Molenberghs, Craig H Mallinckrodt, Raymond J Carroll, 2003, Biological Psychiatry.

The responsiveness of the Hamilton Depression Rating Scale.

D DeBrota, M. Demitrack, W. Potter, 2000, Journal of psychiatric research.

The problem of measurement error in multisite clinical trials.

D DeBrota, M. Demitrack, W. Potter, 1998, Psychopharmacology bulletin.

Determination of pregnancy outcome risk rates after exposure to an intervention

W. Offen, K. L. Sundell, D. DeBrota, 2001, Clinical pharmacology and therapeutics.

Is it easier to find what you are looking for if you think you know what it looks like?

J. Mundt, J. Modell, J. Greist, 2007, Journal of clinical psychopharmacology.

An integrative approach to determine the best behavioral and biological markers of methylphenidate.

C. Clark, L. Williams, D. Hermens, 2007, Journal of integrative neuroscience.

The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology.

E. Gordon, C. Clark, L. Williams, 2005, Journal of integrative neuroscience.

An Examination of 26,168 Hamilton Depression Rating Scale Scores Administered via Interactive Voice Response Across 17 Randomized Clinical Trials

James C Mundt, J. Mundt, J. Modell, 2006, Journal of clinical psychopharmacology.

Optimizing the ability of the Hamilton Depression Rating Scale to discriminate across levels of severity and between antidepressants and placebos

D. Santor, D. DeBrota, S. Gelwicks, 2008, Depression and anxiety.

Medical resident work schedules: design and evaluation by simulation modeling

Robert W. Klein, Robert S. Dittus, David J. DeBrota, 1996 .

Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis

W. Grajkowska, M. Pronicki, R. Banerjee, 2020, Journal of pediatric gastroenterology and nutrition.

Neurophysiologic Correlates of Side Effects in Normal Subjects Randomized to Venlafaxine or Placebo

A. Hunter, A. Leuchter, I. Cook, 2005, Neuropsychopharmacology.

Multinomial Markov-chain model of sleep architecture in Phase Advanced Subjects

Andrew C. Hooker, Mats O. Karlsson, David J. DeBrota, 2013 .

Rating the Raters: Assessing the Quality of Hamilton Rating Scale for Depression Clinical Interviews in Two Industry-sponsored Clinical Drug Trials

Nina Engelhardt, Dawn Sikich, K. O. Cogger, 2006, Journal of clinical psychopharmacology.

Use of Caley-Menger determinants in the calculation of molecular structures

M. Klapper, D. DeBrota, 1980 .